Cargando…

Estimate and determinants of SARS-CoV-2 RNA clearance time among non-severe COVID-19 patients

OBJECTIVES: To estimate SARS-CoV-2 RNA clearance time among non-severe COVID-19 patients and explore factors associated with delayed negative conversion. METHODS: A retrospective cohort study was conducted at the COVID-19 unit of a tertiary care center in the Western region of Saudi Arabia. Reverse...

Descripción completa

Detalles Bibliográficos
Autores principales: Aljunaid, Mohammed A., Albeshry, Abdulrahman M., Alshahrani, Najim Z., Barabie, Samaher S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254785/
https://www.ncbi.nlm.nih.gov/pubmed/35800556
http://dx.doi.org/10.4103/jfmpc.jfmpc_1841_21
_version_ 1784740776414019584
author Aljunaid, Mohammed A.
Albeshry, Abdulrahman M.
Alshahrani, Najim Z.
Barabie, Samaher S.
author_facet Aljunaid, Mohammed A.
Albeshry, Abdulrahman M.
Alshahrani, Najim Z.
Barabie, Samaher S.
author_sort Aljunaid, Mohammed A.
collection PubMed
description OBJECTIVES: To estimate SARS-CoV-2 RNA clearance time among non-severe COVID-19 patients and explore factors associated with delayed negative conversion. METHODS: A retrospective cohort study was conducted at the COVID-19 unit of a tertiary care center in the Western region of Saudi Arabia. Reverse transcriptase-polymerase chain reaction (RT-PCR) confirmed COVID-19 patients diagnosed between April 1 and June 30, 2020, were considered. The primary outcome was the time (days) from disease onset to first negative RT-PCR, which was analyzed using Kaplan–Meier and Cox regression survival methods. Demographic data, clinical history, baseline clinical, radiological and laboratory findings and management, and outcome data were collected and analyzed as factors associated with the viral RNA clearance time. RESULTS: One hundred and forty-four patients were included. The mean (standard deviation [SD]) age was 36.93 (14.41) years, 50.7% were females, and 45.1% were healthcare workers. COVID19 was asymptomatic, mild and moderate in 11.1%, 71.5% and 17.4% of the participants, respectively. Fever (59.4%) and cough (58.0%) were the dominant onset symptoms. The mean viral RNA clearance time was 22.9 days (SD = 8.6; 95% confidence interval [CI] = 21.5–24.3 days). Extended clearance time was associated with older age (mean = 24.0 vs. 22.0 days; log-rank = 0.037), married status (23.2 vs. 22.6 days; log-rank = 0.021), working in health sector (24.2 vs. 21.8 days; log-rank = 0.006), and having a chronic disease (24.8 vs. 21.9 days; log-rank = 0.028), compared to their counterparts, respectively. In the adjusted model, the job sector was the only factor that was independently associated with clearance time. Non-healthcare sector showed hazard ratio 1.8 (95% CI = 1.3–2.7; log-rank = 0.002) with reference to healthcare sector. CONCLUSION: SARS-CoV-2 RNA clearance time is likely to be longer in non-severe COVID-19 patients, representing an additional risk for the virus dissemination among the community and calling for higher caution among the population.
format Online
Article
Text
id pubmed-9254785
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-92547852022-07-06 Estimate and determinants of SARS-CoV-2 RNA clearance time among non-severe COVID-19 patients Aljunaid, Mohammed A. Albeshry, Abdulrahman M. Alshahrani, Najim Z. Barabie, Samaher S. J Family Med Prim Care Original Article OBJECTIVES: To estimate SARS-CoV-2 RNA clearance time among non-severe COVID-19 patients and explore factors associated with delayed negative conversion. METHODS: A retrospective cohort study was conducted at the COVID-19 unit of a tertiary care center in the Western region of Saudi Arabia. Reverse transcriptase-polymerase chain reaction (RT-PCR) confirmed COVID-19 patients diagnosed between April 1 and June 30, 2020, were considered. The primary outcome was the time (days) from disease onset to first negative RT-PCR, which was analyzed using Kaplan–Meier and Cox regression survival methods. Demographic data, clinical history, baseline clinical, radiological and laboratory findings and management, and outcome data were collected and analyzed as factors associated with the viral RNA clearance time. RESULTS: One hundred and forty-four patients were included. The mean (standard deviation [SD]) age was 36.93 (14.41) years, 50.7% were females, and 45.1% were healthcare workers. COVID19 was asymptomatic, mild and moderate in 11.1%, 71.5% and 17.4% of the participants, respectively. Fever (59.4%) and cough (58.0%) were the dominant onset symptoms. The mean viral RNA clearance time was 22.9 days (SD = 8.6; 95% confidence interval [CI] = 21.5–24.3 days). Extended clearance time was associated with older age (mean = 24.0 vs. 22.0 days; log-rank = 0.037), married status (23.2 vs. 22.6 days; log-rank = 0.021), working in health sector (24.2 vs. 21.8 days; log-rank = 0.006), and having a chronic disease (24.8 vs. 21.9 days; log-rank = 0.028), compared to their counterparts, respectively. In the adjusted model, the job sector was the only factor that was independently associated with clearance time. Non-healthcare sector showed hazard ratio 1.8 (95% CI = 1.3–2.7; log-rank = 0.002) with reference to healthcare sector. CONCLUSION: SARS-CoV-2 RNA clearance time is likely to be longer in non-severe COVID-19 patients, representing an additional risk for the virus dissemination among the community and calling for higher caution among the population. Wolters Kluwer - Medknow 2022-05 2022-05-14 /pmc/articles/PMC9254785/ /pubmed/35800556 http://dx.doi.org/10.4103/jfmpc.jfmpc_1841_21 Text en Copyright: © 2022 Journal of Family Medicine and Primary Care https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Aljunaid, Mohammed A.
Albeshry, Abdulrahman M.
Alshahrani, Najim Z.
Barabie, Samaher S.
Estimate and determinants of SARS-CoV-2 RNA clearance time among non-severe COVID-19 patients
title Estimate and determinants of SARS-CoV-2 RNA clearance time among non-severe COVID-19 patients
title_full Estimate and determinants of SARS-CoV-2 RNA clearance time among non-severe COVID-19 patients
title_fullStr Estimate and determinants of SARS-CoV-2 RNA clearance time among non-severe COVID-19 patients
title_full_unstemmed Estimate and determinants of SARS-CoV-2 RNA clearance time among non-severe COVID-19 patients
title_short Estimate and determinants of SARS-CoV-2 RNA clearance time among non-severe COVID-19 patients
title_sort estimate and determinants of sars-cov-2 rna clearance time among non-severe covid-19 patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254785/
https://www.ncbi.nlm.nih.gov/pubmed/35800556
http://dx.doi.org/10.4103/jfmpc.jfmpc_1841_21
work_keys_str_mv AT aljunaidmohammeda estimateanddeterminantsofsarscov2rnaclearancetimeamongnonseverecovid19patients
AT albeshryabdulrahmanm estimateanddeterminantsofsarscov2rnaclearancetimeamongnonseverecovid19patients
AT alshahraninajimz estimateanddeterminantsofsarscov2rnaclearancetimeamongnonseverecovid19patients
AT barabiesamahers estimateanddeterminantsofsarscov2rnaclearancetimeamongnonseverecovid19patients